3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
2
Neuralgia
2
Neoplasms
2
Lung Neoplasms
2
Leiomyoma
2
Sexual Dysfunction, Physiological
1
Scleroderma, Localized
1
Pneumonia
1
Pain
1
Neuropathy, Painful
1
Neurofibromatoses
1
Neurodermatitis
1
Neoplasms, Cystic, Mucinous, and Serous
1
Mastodynia
1
Lymphoma, Follicular
1
Lichen Planus
1
Leukemia-Lymphoma
1
Kidney Neoplasms
1
Keratoacanthoma
1
Keloid
1
Ileus
1
Hydrocephalus
1
Hordeolum
1
Headache
1
Granuloma Annulare
1
Eyelid Neoplasms
1
Epilepsy
1
Dermoid Cyst
1
Colorectal Neoplasms
1
Cold Hypersensitivity
1
Interventions
Sorafenib
23
Bevacizumab
11
Radiosurgery
6
Capecitabine
6
Radiofrequency Ablation
5
Oxaliplatin
5
Fluorouracil
5
Doxorubicin
5
pembrolizumab
4
Sunitinib
4
Erlotinib Hydrochloride
4
Cisplatin
4
Ramucirumab
3
Radiotherapy
3
Nivolumab
3
Leucovorin
3
Carboplatin
3
tremelimumab
2
spartalizumab
2
perflutren
2
derazantinib
2
carotuximab
2
Mitomycin
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Ipilimumab
2
Immunohistochemistry
2
Gemcitabine
2
Folfox protocol
2
Fluorodeoxyglucose F18
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Liver Neoplasms
×
Lidocaine
×
Clear all
No trials found.